Stock COCP COCRYSTAL PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cocrystal Pharma, Inc.

Equities

COCP

US19188J4094

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
1.562 USD +2.76% Intraday chart for Cocrystal Pharma, Inc. +6.99% -9.30%
Mar. 28 Cocrystal Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 04 Cocrystal Pharma, Inc. Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investment Candidates CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Cocrystal Pharma's Price Target to $12 From $35, Keeps Buy Rating
MT
HC Wainwright Adjusts Price Target on Cocrystal Pharma to $35 From $42, Maintains Buy Rating
MT
HC Wainwright Adjusts Price Target on Cocrystal Pharma to $42 From $48, Maintains Buy Rating
MT
COCRYSTAL PHARMA : HC Wainwright Adjusts Cocrystal Pharma PT to $4 From $4.50, Maintains Buy Rating
MT
COCRYSTAL PHARMA : HC Wainwright Adjusts Cocrystal Pharma Price Target to $4.50 From $5, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. COCP Stock
  4. News Cocrystal Pharma, Inc.
  5. Analyst Reco.